---
title: "On the morning of the first session of the 2025 National Negotiation, 6 pharmaceutical companies have completed negotiations and exited, involving products including analgesics and anti-infectives"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263411791.md"
description: "The national medical insurance catalog on-site negotiations for 2025 were held on October 30, with 6 pharmaceutical companies completing the negotiations and leaving, involving analgesics and anti-infection drugs. Participating companies include Haisco, Yifan Pharmaceutical, Astrazeneca, CSPC PHARMA, and LUYE PHARMA. Astrazeneca Vice President Huang Bin left the negotiations with a smile"
datetime: "2025-10-30T02:30:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263411791.md)
  - [en](https://longbridge.com/en/news/263411791.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263411791.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263411791.md) | [繁體中文](https://longbridge.com/zh-HK/news/263411791.md)


# On the morning of the first session of the 2025 National Negotiation, 6 pharmaceutical companies have completed negotiations and exited, involving products including analgesics and anti-infectives

On October 30th, reporters learned from the on-site negotiations for the 2025 National Medical Insurance Catalog and the price negotiations for innovative drugs under commercial insurance that the representatives of companies entering the venue this morning included Haisco, Yifan Pharmaceutical, Astrazeneca, CSPC PHARMA, LUYE PHARMA, and several other pharmaceutical companies. It is estimated that the varieties involved include multiple medications such as analgesics and anti-infectives. Around 9:30, the first batch of negotiation representatives completed their negotiations and left the venue in order. The reporter noted that the Astrazeneca negotiation representative was still Astrazeneca Vice President Huang Bin, who left the venue smiling and wearing the iconic red scarf around 9:36

### Related Stocks

- [AstraZeneca PLC (AZN.US)](https://longbridge.com/en/quote/AZN.US.md)
- [CSPC PHARMA (01093.HK)](https://longbridge.com/en/quote/01093.HK.md)
- [LUYE PHARMA (02186.HK)](https://longbridge.com/en/quote/02186.HK.md)
- [Haisco (002653.CN)](https://longbridge.com/en/quote/002653.CN.md)
- [Yifan Pharmaceutical (002019.CN)](https://longbridge.com/en/quote/002019.CN.md)

## Related News & Research

- [AstraZeneca and Daiichi secure US fast-track status for cancer drug](https://longbridge.com/en/news/278343765.md)
- [Legacy Capital Group California Inc. Buys New Position in AstraZeneca PLC $AZN](https://longbridge.com/en/news/278263981.md)
- [AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu](https://longbridge.com/en/news/278455555.md)
- [If You Invested $100 In AstraZeneca Stock 5 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/277223612.md)
- [InSilico Out-licensed Drug ISM4808 Begins Clinical Trial](https://longbridge.com/en/news/278010381.md)